BNV-220

N/A

Report date: 2023/01/14 16:58:34
NME

Base Information

Drug NameBNV-220
Drug Alias NameBNV-220
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUndefined mechanism
TargetsNot applicable
Therapy Area/IndicationsAcute Pain
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesBionevia Pharmaceuticals
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBionevia Pharmaceuticals
Active IndicationsN/A
Inactive IndicationsAcute Pain

Other Information

ATC CodeN/A
Related LinksN/A